BMS-986326
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BMS-986326, covering 2024-05-06 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus [Phase 1]